Summary
The effect of low doses of clonidine on exploration and motility was investigated in rats after destruction of central noradrenergic systems by 6-hydroxydopamine (6-OHDA) or DSP-4. In accordance with previous results, clonidine decreased exploration and motility in control animals. This sedative effect of clonidine was potentiated in animals that suffered selective and extensive depletions of brain NA as a result of neonatal treatment with 6-OHDA. Depletion of NA by administration of DSP-4 to adult animals did not influence clonidine's sedative effects. Yohimbine, but not phentolamine, antagonized clonidine-induced hypomotility both in control and in neonatal 6-OHDA treated groups. The results suggest that clonidineinduced sedation is mediated by postsynapticα 2-adrenoreceptors.
Similar content being viewed by others
References
Andén, N.-E., Corrodi, H., Fuxe, K., Hokfelt, B., Hokfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci.9, 513–523 (1970).
Andén, N.-E., Grabowska, M., Strombom, U.: Differentα-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol.293, 43–52 (1976).
Angelletti, P. U.: Chemical sympathectomy in newborn animals. Neuropharmacology10, 55–59 (1971).
Bruner, H., Klein, K. E.: Experimentelle Untersuchungen über die Veränderungen der Psychomotorischen Leistungsbereitschaft unter dem Einfluss eines Antihypertonicums. In: Hochdrucktherapie (Heilmeyer, L., Holtmeier, H.-J., Pfeiffer, E. F., Hrsg.), S. 180–184. Stuttgart: G. Thieme. 1968.
Cedarbaum, J. M., Agbajanian, G. K.: Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by theα-antagonist piperoxane. Brain Res.112, 413–419 (1976).
Cedarbaum, J. M., Aghajanian, G. K.: Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur. J. Pharm.44, 375–385 (1977).
Clark, D. W. J., Laverty, R., Phelan, E. L.: Long-lasting peripheral and central effects of 6-hydroxydopamine in rats. Brit. J. Pharmac.44, 233–243 (1972).
Davis, M., Cedarbaum, J. M., Aghajanian, G. K., Gendelman, D. S.: Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats. Psychopharmacology51, 243–253 (1977).
Drew, G. M., Gower, A. J., Marriott, A. S.:α 2-adrenoreceptors mediate clonidine-induced sedation in the rat. Brit. J. Pharmac.67, 133–141 (1979).
Delini-Stula, A., Baumann, P., Buch, O.: Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and post-synaptic central noradrenergic receptor selectivity ofα-adrenolytic drugs. Naunyn-Schmiedeberg's Arch. Pharmacol.307, 115–122 (1979).
Haeusler, G.: Clonidine induced-inhibition of sympathetic nerve activity: No indication of presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol.286, 97–111 (1974).
Jaim-Etcheverry, G., Zieher, L. M.: DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats. Brain Res.188, 513–523 (1980).
Kobinger, W.: Centralα-adrenergic system as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol.81, 39–100 (1978).
Langer, S. Z.: Presynaptic receptors and their role in the regulation of transmitter release. Sixth Gaddum Memorial Lecture. Br. J. Pharmacol.60, 481–497 (1977).
Langer, S. Z.: Presynaptic regulation of the release of catecholamines. Pharmac. Reviews32, 337–362 (1981).
Langer, S. Z., Massingham, R.:α-adrenoreceptors and the clinical pharmacology of clonidine. Proc. World Conference on Clinical Pharmacology and Therapeutics (Turner, P., ed.), pp. 158–164. New York: Macmillan. 1980.
Laverty, R., Taylor, K. M.: Behavioral and biochemical effects of 2-(2, 6-dichlorolophenylamino)-2-imidazoline hydrochloride (ST155) on the central nervous system. Br. J. Pharmac.35, 253–264 (1969).
McGeer, E. G., McGeer, P. L.: Catecholamine content of the spinal cord. Can. J. Biochem.40, 1141–1151 (1962).
Ross, S. B.: Long-term effect of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Brit. J. Pharmacol.58, 521–527 (1976).
Schmitt, H.: The pharmacology of clonidine and related products. In: Antihypertensive Agents (Gross, F., ed.), pp.299–378. Berlin-Heidelberg-New York: Springer. 1977.
Skolnick, P., Daly, J. W., Segal, D. S.: Neurochemical and behavioral effects of clonidine and related imidazolines: Interaction with α-adrenoreceptors. Eur. J. Pharmacol.47, 451–455 (1978).
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Pharmacol.77, 1–124 (1977).
Strombom, U.: Effects of low doses of catecholamine receptor agonists on exploration in mice. J. Neural Transm.37, 229–235 (1975).
Strombom, U.: Catecholamine receptor agonists: Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol.292, 167–176 (1976).
Strombom, U., Svensson, T.: Clonidine: Attenuation of sedative action by facilitated central noradrenergic neurotransmission. J. Neural Transm.47, 29–39 (1980).
Svensson, T. H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by theα-adrenergic agonist clonidine. Brain Res.92, 291–306 (1975).
Taylor, K. M., Clark, D. W. J., Laverty, R., Phelan, E. L.: Specific noradrenergic neurons destroyed by 6-hydroxydopamine injection into newborn rats. Nature New Biol.239, 247–248 (1972).
U'Prichard, D. C., Bechtel, W. P., Rouot, B. M., Snyder, S. H.: Multiple apparentα-noradrenergic receptor binding sites in rat brain. Effect of 6-hydroxydopamine. Mol. Pharmacol.16, 47–60 (1979).
U'Prichard, D. C., Reisine, T. D., Mason, S. T., Fibiger, H. C., Yamamura, H. I.: Modulation of rat brainα- andβ-adrenergic receptor population by lesion of the dorsal noradrenergic bundle. Brain Res.187, 143–154 (1980).
Van Zwieten, P. A.: Antihypertensive drugs with a central action. In: Progress in Pharmacology, pp. 1–63. Stuttgart: Gustav Fischer-Verlag. 1975.
Westfall, T. C.: Local regulation of adrenergic neurotransmission. Physiol. Rev.57, 659–728 (1977).
Whishaw, I. Q., Cooper, R. M.: Strychnine and suppression of exploration. Physiol. Behav.5, 647–649 (1970).
Zebrowska-Lupina, L., Przegalinski, E., Sloniec, M., Kleinrok, Z.: Clonidine-induced hyperactivity in rats. The role of central postsynapticα-adrenoreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol.297, 227–231 (1977).
Zis, A. P., Fibiger, H. C.: Functional evidence for postsynaptic supersensitivity of central noradrenergic receptors after denervation. Nature256, 659–661 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spyraki, C., Fibiger, H.C. Clonidine-induced sedation in rats: Evidence for mediation by postsynapticα 2-adrenoreceptors. J. Neural Transmission 54, 153–163 (1982). https://doi.org/10.1007/BF01254925
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01254925